IL115027A - N-substituted phenothiazines their preparation pharmaceutical compositions containing them and their use - Google Patents
N-substituted phenothiazines their preparation pharmaceutical compositions containing them and their useInfo
- Publication number
- IL115027A IL115027A IL11502795A IL11502795A IL115027A IL 115027 A IL115027 A IL 115027A IL 11502795 A IL11502795 A IL 11502795A IL 11502795 A IL11502795 A IL 11502795A IL 115027 A IL115027 A IL 115027A
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- preparation pharmaceutical
- substituted phenothiazines
- phenothiazines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
- C07D279/22—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
- C07D279/24—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom with hydrocarbon radicals, substituted by amino radicals, attached to the ring nitrogen atom
- C07D279/26—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom with hydrocarbon radicals, substituted by amino radicals, attached to the ring nitrogen atom without other substituents attached to the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
- C07D279/22—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
- C07D279/24—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom with hydrocarbon radicals, substituted by amino radicals, attached to the ring nitrogen atom
- C07D279/28—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom with hydrocarbon radicals, substituted by amino radicals, attached to the ring nitrogen atom with other substituents attached to the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
- C07D279/22—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
- C07D279/30—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom with acyl radicals attached to the ring nitrogen atom
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4430091A DE4430091A1 (de) | 1994-08-25 | 1994-08-25 | Verwendung von N-substituierten Phenothiazinen |
Publications (2)
Publication Number | Publication Date |
---|---|
IL115027A0 IL115027A0 (en) | 1995-12-08 |
IL115027A true IL115027A (en) | 2000-01-31 |
Family
ID=6526496
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11502795A IL115027A (en) | 1994-08-25 | 1995-08-22 | N-substituted phenothiazines their preparation pharmaceutical compositions containing them and their use |
Country Status (11)
Country | Link |
---|---|
US (1) | US5861394A (de) |
EP (1) | EP0777481A1 (de) |
JP (1) | JPH10504820A (de) |
AU (1) | AU3345395A (de) |
CA (1) | CA2198256A1 (de) |
DE (1) | DE4430091A1 (de) |
IL (1) | IL115027A (de) |
MY (1) | MY132077A (de) |
TW (1) | TW408117B (de) |
WO (1) | WO1996005837A1 (de) |
ZA (1) | ZA957113B (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9506197D0 (en) | 1995-03-27 | 1995-05-17 | Hoffmann La Roche | Inhibition of tau-tau association. |
AU3633997A (en) * | 1996-07-29 | 1998-02-20 | Banyu Pharmaceutical Co., Ltd. | Chemokine receptor antagonists |
US6436972B1 (en) | 2000-04-10 | 2002-08-20 | Dalhousie University | Pyridones and their use as modulators of serine hydrolase enzymes |
CA2310205A1 (en) * | 2000-05-29 | 2001-11-29 | Dalhousie University | Unknown |
GB0100119D0 (en) | 2001-01-03 | 2001-02-14 | Univ Aberdeen | Materials and methods relating to protein aggregation in neurodegenerative disease |
GB0101049D0 (en) | 2001-01-15 | 2001-02-28 | Univ Aberdeen | Materials and methods relating to protein aggregation in neurodegenerative disease |
GB0106953D0 (en) * | 2001-03-20 | 2001-05-09 | Univ Aberdeen | Neufofibrillary labels |
JP5186212B2 (ja) | 2004-09-23 | 2013-04-17 | ウィスタ ラボラトリーズ リミテッド | メチルチオニニウム塩化物(mtc)などのジアミノフェノチアジニウム化合物を化学合成および精製する方法 |
CN104119294B (zh) | 2006-03-29 | 2018-10-30 | 维斯塔实验室有限公司 | 3,7-二氨基-10h-吩噻嗪化合物的制备方法 |
CN103735554B (zh) | 2006-03-29 | 2018-03-20 | 维斯塔实验室有限公司 | 蛋白聚集抑制剂 |
GB0614365D0 (en) * | 2006-07-19 | 2006-08-30 | Proaxon Ltd | Pharmaceutical compositions and their use |
DE102010062810B4 (de) * | 2010-09-07 | 2014-03-13 | Immungenetics Ag | 2-(R2-Thio)-10-[3-(4-R1-piperazin-1-yl)propyl]-10H-phenothiazine zur Behandlung neurodegenerativer Erkrankungen ausgewählt aus beta-Amyloidopathien und alpha-Synucleinopathien |
SI2673266T1 (sl) | 2011-02-11 | 2016-11-30 | Wista Laboratories Ltd. | Fenotiazin diaminijeve soli in njihova uporaba |
AU2017311691B2 (en) | 2016-08-18 | 2021-12-02 | Vidac Pharma Ltd. | Piperazine derivatives, pharmaceutical compositions and methods of use thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR7430M (de) * | 1968-05-06 | 1969-11-17 | ||
FR2303542A1 (fr) * | 1975-03-12 | 1976-10-08 | Fabre Sa Pierre | Amides de la pyrrolidino ethyl amine utilisables en therapeutique pulmonaire |
FR2326194A1 (fr) * | 1975-10-02 | 1977-04-29 | Fabre Sa Pierre | Phenothiazines carboxamides utilisables dans le traitement des syndromes extra-pyramidaux et de la maladie de parkinson |
JPS56166183A (en) * | 1980-05-26 | 1981-12-21 | Showa Denko Kk | Phenothazine derivative and carcinostatic agent |
US4666907A (en) * | 1983-10-05 | 1987-05-19 | Merck Frosst Canada, Inc. | Phenothiazine and derivatives and analogs and use as leukotriene biosynthesis inhibitors |
US4833138A (en) * | 1987-10-23 | 1989-05-23 | Washington University | Phenothiazinealkaneamines for treatment of neurotoxic injury |
FR2689013B1 (fr) * | 1992-03-30 | 1995-05-05 | Rhone Poulenc Rorer Sa | Nouvelle application thérapeutique des dérivés de la phénothiazine. |
-
1994
- 1994-08-25 DE DE4430091A patent/DE4430091A1/de not_active Withdrawn
-
1995
- 1995-07-14 TW TW084107282A patent/TW408117B/zh active
- 1995-08-14 EP EP95929864A patent/EP0777481A1/de not_active Ceased
- 1995-08-14 CA CA002198256A patent/CA2198256A1/en not_active Abandoned
- 1995-08-14 AU AU33453/95A patent/AU3345395A/en not_active Abandoned
- 1995-08-14 JP JP8507759A patent/JPH10504820A/ja active Pending
- 1995-08-14 US US08/793,619 patent/US5861394A/en not_active Expired - Fee Related
- 1995-08-14 WO PCT/EP1995/003212 patent/WO1996005837A1/de not_active Application Discontinuation
- 1995-08-18 MY MYPI95002437A patent/MY132077A/en unknown
- 1995-08-22 IL IL11502795A patent/IL115027A/xx not_active IP Right Cessation
- 1995-08-24 ZA ZA957113A patent/ZA957113B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
DE4430091A1 (de) | 1996-02-29 |
JPH10504820A (ja) | 1998-05-12 |
CA2198256A1 (en) | 1996-02-29 |
ZA957113B (en) | 1996-04-15 |
AU3345395A (en) | 1996-03-14 |
US5861394A (en) | 1999-01-19 |
WO1996005837A1 (de) | 1996-02-29 |
EP0777481A1 (de) | 1997-06-11 |
IL115027A0 (en) | 1995-12-08 |
TW408117B (en) | 2000-10-11 |
MY132077A (en) | 2007-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL114578A0 (en) | Amino purine-béta-D ribofuranuronamide derivatives their preparation pharmaceutical compositions containing them and their use | |
IL114626A0 (en) | 6-membered nitrogen-containing heteroaryl-oxazolidinones their preparation and pharmaceutical compositions containing them | |
IL114622A0 (en) | Heteroaryl-oxazolidinones and pharmaceutical compositions containing them | |
IL116517A0 (en) | Piperazine derivatives their preparation and pharmaceutical compositions containing them | |
HUS1200028I1 (hu) | 4"-Szubsztituált-9-dezoxo-9a-aza-9a-homoeritromicin-származékok és ezeket tartalmazó gyógyszerek | |
IL114759A (en) | Benzoxazole derivatives and pharmaceutical compositions containing them | |
IL113814A0 (en) | Diketopiperazine derivatives their preparation pharmaceutical compositions containing them and their use | |
IL114492A0 (en) | Benzimidazole derivatives their preparation and pharmaceutical compositions containing them | |
IL114925A (en) | Glycinamide derivatives their preparation and pharmaceutical compositions containing them | |
IL117349A0 (en) | N-(3-benyofuranyl) urea-derivatives their preparation and pharmaceutical compositions containing them | |
IL115905A0 (en) | Sordarin derivatives their preparation and pharmaceutical compositions containing them | |
IL125710A0 (en) | Arylglycinamide derivatives their preparation and pharmaceutical compositions containing them | |
IL115072A0 (en) | Substituted 4-phenyl-6-amino-nicotinic acid derivatives their preparation pharmaceutical compositions containing them and their use | |
IL115027A0 (en) | N-substituted phenothiazines their preparation pharmaceutical compositions containing them and their use | |
IL113329A (en) | Pharmaceutical compositions containing n-substituted benzamides | |
IL114572A0 (en) | Benzamine pharmaceutical compositions containing it its preparation and use | |
IL114955A (en) | N-substituted naphthofused lactams and pharmaceutical compositions containing them | |
IL116101A0 (en) | Benzamide its preparation and pharmaceutical compositions containing it | |
IL114623A0 (en) | Substituted triazolylmethylphenylnaph-thyridones their preparation and pharmaceutical compositions containing them | |
ZA948689B (en) | New taxicin derivatives their preparation and pharmaceutical compositions containing them | |
IL112567A (en) | Substituted quinolines their preparation and pharmaceutical compositions containing them | |
IL116082A0 (en) | Oxazoles their preparation and pharmaceutical compositions containing them | |
IL115982A (en) | Cyclolignan derivatives and pharmaceutical compositions containing them | |
IL113415A0 (en) | Dihydrodibenzoquinolinediones their preparation and use and pharmaceutical compositions containing them | |
ZA933426B (en) | New dihydroxybenzylamine derivatives their preparation and pharmaceutical compositions which contain them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |